Barrett Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-844
Closed -$113K 292
2021
Q4
$113K Buy
844
+4
+0.5% +$575 ﹤0.01% 286
2021
Q3
$115K Hold
840
0.01% 246
2021
Q2
$90K Hold
840
﹤0.01% 258
2021
Q1
$75K Hold
840
﹤0.01% 263
2020
Q4
$78K Hold
840
﹤0.01% 234
2020
Q3
$87K Buy
+840
New +$87.8K 0.01% 215

Other funds holding DXCM

Barrett Asset Management's DXCM Position: Q1 2022 in Review

Barrett Asset Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 844 shares — an estimated $113K sold.

Barrett Asset Management first reported a position in DXCM in Q3 2020 and held it in 6 quarters. The position peaked at $115K in Q3 2021. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Barrett Asset Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Barrett Asset Management sold 844 DexCom shares in Q1 2022, an estimated $113K.
  • Barrett Asset Management first reported a position in DexCom in Q3 2020 and held it in 6 quarters.
  • Barrett Asset Management's DexCom position peaked at $115K in Q3 2021.
  • 862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.